nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—BCHE—Ramipril—type 2 diabetes mellitus	0.596	1	CbGbCtD
Pralidoxime—Excitement—Irbesartan—type 2 diabetes mellitus	0.00777	0.0379	CcSEcCtD
Pralidoxime—Diplopia—Glipizide—type 2 diabetes mellitus	0.00507	0.0247	CcSEcCtD
Pralidoxime—Diplopia—Bromocriptine—type 2 diabetes mellitus	0.00427	0.0208	CcSEcCtD
Pralidoxime—Drowsiness—Glipizide—type 2 diabetes mellitus	0.0039	0.019	CcSEcCtD
Pralidoxime—Diplopia—Glyburide—type 2 diabetes mellitus	0.0039	0.019	CcSEcCtD
Pralidoxime—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.00364	0.0178	CcSEcCtD
Pralidoxime—Diplopia—Gliclazide—type 2 diabetes mellitus	0.0035	0.0171	CcSEcCtD
Pralidoxime—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.00329	0.016	CcSEcCtD
Pralidoxime—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00288	0.014	CcSEcCtD
Pralidoxime—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.00284	0.0138	CcSEcCtD
Pralidoxime—Nausea—Miglitol—type 2 diabetes mellitus	0.00273	0.0133	CcSEcCtD
Pralidoxime—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.0027	0.0132	CcSEcCtD
Pralidoxime—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00268	0.0131	CcSEcCtD
Pralidoxime—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00267	0.013	CcSEcCtD
Pralidoxime—Agitation—Glimepiride—type 2 diabetes mellitus	0.00262	0.0128	CcSEcCtD
Pralidoxime—Headache—Tolbutamide—type 2 diabetes mellitus	0.00258	0.0126	CcSEcCtD
Pralidoxime—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00248	0.0121	CcSEcCtD
Pralidoxime—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00248	0.0121	CcSEcCtD
Pralidoxime—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00245	0.012	CcSEcCtD
Pralidoxime—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.00244	0.0119	CcSEcCtD
Pralidoxime—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00242	0.0118	CcSEcCtD
Pralidoxime—Agitation—Bromocriptine—type 2 diabetes mellitus	0.00236	0.0115	CcSEcCtD
Pralidoxime—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00235	0.0115	CcSEcCtD
Pralidoxime—Headache—Tolazamide—type 2 diabetes mellitus	0.00235	0.0115	CcSEcCtD
Pralidoxime—Headache—Linagliptin—type 2 diabetes mellitus	0.00233	0.0114	CcSEcCtD
Pralidoxime—Dizziness—Nateglinide—type 2 diabetes mellitus	0.0023	0.0112	CcSEcCtD
Pralidoxime—Muscular weakness—Losartan—type 2 diabetes mellitus	0.00229	0.0112	CcSEcCtD
Pralidoxime—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00227	0.0111	CcSEcCtD
Pralidoxime—Drowsiness—Metformin—type 2 diabetes mellitus	0.00226	0.011	CcSEcCtD
Pralidoxime—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.00224	0.0109	CcSEcCtD
Pralidoxime—Nausea—Tolazamide—type 2 diabetes mellitus	0.00223	0.0109	CcSEcCtD
Pralidoxime—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00223	0.0109	CcSEcCtD
Pralidoxime—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.00223	0.0109	CcSEcCtD
Pralidoxime—Somnolence—Glipizide—type 2 diabetes mellitus	0.00221	0.0108	CcSEcCtD
Pralidoxime—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00221	0.0108	CcSEcCtD
Pralidoxime—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.00221	0.0108	CcSEcCtD
Pralidoxime—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.0022	0.0107	CcSEcCtD
Pralidoxime—Nausea—Acarbose—type 2 diabetes mellitus	0.00214	0.0104	CcSEcCtD
Pralidoxime—Pain—Glipizide—type 2 diabetes mellitus	0.00213	0.0104	CcSEcCtD
Pralidoxime—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00207	0.0101	CcSEcCtD
Pralidoxime—Nausea—Nateglinide—type 2 diabetes mellitus	0.00207	0.0101	CcSEcCtD
Pralidoxime—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00206	0.01	CcSEcCtD
Pralidoxime—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00998	CcSEcCtD
Pralidoxime—Pain—Sitagliptin—type 2 diabetes mellitus	0.00198	0.00966	CcSEcCtD
Pralidoxime—Agitation—Gliclazide—type 2 diabetes mellitus	0.00194	0.00945	CcSEcCtD
Pralidoxime—Headache—Repaglinide—type 2 diabetes mellitus	0.00189	0.0092	CcSEcCtD
Pralidoxime—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00188	0.00918	CcSEcCtD
Pralidoxime—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00186	0.00909	CcSEcCtD
Pralidoxime—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00183	0.00891	CcSEcCtD
Pralidoxime—Vision blurred—Orlistat—type 2 diabetes mellitus	0.0018	0.0088	CcSEcCtD
Pralidoxime—Nausea—Repaglinide—type 2 diabetes mellitus	0.00179	0.00872	CcSEcCtD
Pralidoxime—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00178	0.00869	CcSEcCtD
Pralidoxime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00169	0.00824	CcSEcCtD
Pralidoxime—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00168	0.00819	CcSEcCtD
Pralidoxime—Vision blurred—Metformin—type 2 diabetes mellitus	0.00166	0.00811	CcSEcCtD
Pralidoxime—Dizziness—Glipizide—type 2 diabetes mellitus	0.00165	0.00803	CcSEcCtD
Pralidoxime—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00158	0.0077	CcSEcCtD
Pralidoxime—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00157	0.00765	CcSEcCtD
Pralidoxime—Headache—Glipizide—type 2 diabetes mellitus	0.00156	0.00761	CcSEcCtD
Pralidoxime—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00154	0.0075	CcSEcCtD
Pralidoxime—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00153	0.00747	CcSEcCtD
Pralidoxime—Agitation—Irbesartan—type 2 diabetes mellitus	0.00153	0.00746	CcSEcCtD
Pralidoxime—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00153	0.00746	CcSEcCtD
Pralidoxime—Headache—Pioglitazone—type 2 diabetes mellitus	0.00149	0.00729	CcSEcCtD
Pralidoxime—Nausea—Glipizide—type 2 diabetes mellitus	0.00148	0.00722	CcSEcCtD
Pralidoxime—Vision blurred—Losartan—type 2 diabetes mellitus	0.00148	0.0072	CcSEcCtD
Pralidoxime—Pain—Gliclazide—type 2 diabetes mellitus	0.00147	0.00718	CcSEcCtD
Pralidoxime—Headache—Glimepiride—type 2 diabetes mellitus	0.00146	0.0071	CcSEcCtD
Pralidoxime—Headache—Sitagliptin—type 2 diabetes mellitus	0.00145	0.00708	CcSEcCtD
Pralidoxime—Agitation—Losartan—type 2 diabetes mellitus	0.00144	0.00702	CcSEcCtD
Pralidoxime—Somnolence—Valsartan—type 2 diabetes mellitus	0.00141	0.00686	CcSEcCtD
Pralidoxime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00139	0.00676	CcSEcCtD
Pralidoxime—Nausea—Glimepiride—type 2 diabetes mellitus	0.00138	0.00673	CcSEcCtD
Pralidoxime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00671	CcSEcCtD
Pralidoxime—Pain—Orlistat—type 2 diabetes mellitus	0.00134	0.00652	CcSEcCtD
Pralidoxime—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00133	0.00647	CcSEcCtD
Pralidoxime—Headache—Bromocriptine—type 2 diabetes mellitus	0.00131	0.00641	CcSEcCtD
Pralidoxime—Somnolence—Metformin—type 2 diabetes mellitus	0.00128	0.00624	CcSEcCtD
Pralidoxime—Tachycardia—Losartan—type 2 diabetes mellitus	0.00125	0.00609	CcSEcCtD
Pralidoxime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00125	0.00607	CcSEcCtD
Pralidoxime—Agitation—Ramipril—type 2 diabetes mellitus	0.00123	0.00602	CcSEcCtD
Pralidoxime—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00121	0.00589	CcSEcCtD
Pralidoxime—Headache—Glyburide—type 2 diabetes mellitus	0.0012	0.00586	CcSEcCtD
Pralidoxime—Pain—Irbesartan—type 2 diabetes mellitus	0.00116	0.00567	CcSEcCtD
Pralidoxime—Nausea—Glyburide—type 2 diabetes mellitus	0.00114	0.00555	CcSEcCtD
Pralidoxime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00114	0.00555	CcSEcCtD
Pralidoxime—Somnolence—Losartan—type 2 diabetes mellitus	0.00114	0.00554	CcSEcCtD
Pralidoxime—Pain—Losartan—type 2 diabetes mellitus	0.00109	0.00533	CcSEcCtD
Pralidoxime—Headache—Gliclazide—type 2 diabetes mellitus	0.00108	0.00526	CcSEcCtD
Pralidoxime—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00107	0.00522	CcSEcCtD
Pralidoxime—Dizziness—Valsartan—type 2 diabetes mellitus	0.00105	0.0051	CcSEcCtD
Pralidoxime—Dizziness—Orlistat—type 2 diabetes mellitus	0.00103	0.00504	CcSEcCtD
Pralidoxime—Nausea—Gliclazide—type 2 diabetes mellitus	0.00102	0.00499	CcSEcCtD
Pralidoxime—Headache—Valsartan—type 2 diabetes mellitus	0.00099	0.00483	CcSEcCtD
Pralidoxime—Headache—Orlistat—type 2 diabetes mellitus	0.000979	0.00477	CcSEcCtD
Pralidoxime—Somnolence—Ramipril—type 2 diabetes mellitus	0.000975	0.00475	CcSEcCtD
Pralidoxime—Dizziness—Metformin—type 2 diabetes mellitus	0.000952	0.00464	CcSEcCtD
Pralidoxime—Nausea—Valsartan—type 2 diabetes mellitus	0.000939	0.00458	CcSEcCtD
Pralidoxime—Nausea—Orlistat—type 2 diabetes mellitus	0.000928	0.00453	CcSEcCtD
Pralidoxime—Headache—Metformin—type 2 diabetes mellitus	0.000902	0.0044	CcSEcCtD
Pralidoxime—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000899	0.00438	CcSEcCtD
Pralidoxime—Nausea—Metformin—type 2 diabetes mellitus	0.000855	0.00417	CcSEcCtD
Pralidoxime—Headache—Irbesartan—type 2 diabetes mellitus	0.000851	0.00415	CcSEcCtD
Pralidoxime—Dizziness—Losartan—type 2 diabetes mellitus	0.000846	0.00412	CcSEcCtD
Pralidoxime—Nausea—Irbesartan—type 2 diabetes mellitus	0.000807	0.00394	CcSEcCtD
Pralidoxime—Headache—Losartan—type 2 diabetes mellitus	0.000801	0.00391	CcSEcCtD
Pralidoxime—Nausea—Losartan—type 2 diabetes mellitus	0.00076	0.0037	CcSEcCtD
Pralidoxime—Dizziness—Ramipril—type 2 diabetes mellitus	0.000725	0.00354	CcSEcCtD
Pralidoxime—Headache—Ramipril—type 2 diabetes mellitus	0.000687	0.00335	CcSEcCtD
Pralidoxime—Nausea—Ramipril—type 2 diabetes mellitus	0.000651	0.00318	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000273	0.00137	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000272	0.00136	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CDO1—type 2 diabetes mellitus	0.000271	0.00136	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPD2—type 2 diabetes mellitus	0.000271	0.00136	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000268	0.00135	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000265	0.00133	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000263	0.00132	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000263	0.00132	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AK1—type 2 diabetes mellitus	0.000258	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000255	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGDS—type 2 diabetes mellitus	0.000255	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AANAT—type 2 diabetes mellitus	0.000255	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00025	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000243	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000242	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CDO1—type 2 diabetes mellitus	0.000242	0.00121	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPD2—type 2 diabetes mellitus	0.000242	0.00121	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CALM1—type 2 diabetes mellitus	0.00024	0.00121	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000239	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MAT1A—type 2 diabetes mellitus	0.000239	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000238	0.00119	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000236	0.00119	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000235	0.00118	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000234	0.00118	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000233	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000231	0.00116	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AK1—type 2 diabetes mellitus	0.000231	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—G6PC—type 2 diabetes mellitus	0.00023	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HBA2—type 2 diabetes mellitus	0.00023	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENPP1—type 2 diabetes mellitus	0.00023	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ND1—type 2 diabetes mellitus	0.00023	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.00023	0.00116	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000228	0.00114	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000226	0.00113	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCGR—type 2 diabetes mellitus	0.000223	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000222	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000218	0.0011	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000217	0.00109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000215	0.00108	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CALM1—type 2 diabetes mellitus	0.000214	0.00108	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000213	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MAT1A—type 2 diabetes mellitus	0.000213	0.00107	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000213	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000212	0.00106	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYTB—type 2 diabetes mellitus	0.000211	0.00106	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—OXCT1—type 2 diabetes mellitus	0.000211	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000208	0.00104	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000206	0.00104	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000206	0.00104	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HBA2—type 2 diabetes mellitus	0.000206	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—G6PC—type 2 diabetes mellitus	0.000206	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENPP1—type 2 diabetes mellitus	0.000206	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ND1—type 2 diabetes mellitus	0.000206	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000206	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000205	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000202	0.00101	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCGR—type 2 diabetes mellitus	0.000199	0.001	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ACACA—type 2 diabetes mellitus	0.000196	0.000984	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000196	0.000984	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—STAR—type 2 diabetes mellitus	0.000196	0.000984	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000195	0.000978	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000195	0.000977	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000193	0.000969	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000192	0.000962	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.00019	0.000952	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000188	0.000946	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—OXCT1—type 2 diabetes mellitus	0.000188	0.000944	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYTB—type 2 diabetes mellitus	0.000188	0.000944	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000188	0.000943	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CBS—type 2 diabetes mellitus	0.000188	0.000943	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000183	0.00092	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000181	0.000909	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000181	0.000908	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COX2—type 2 diabetes mellitus	0.000181	0.000908	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.00018	0.000903	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000178	0.000894	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000178	0.000892	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000178	0.000891	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000175	0.000879	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACACA—type 2 diabetes mellitus	0.000175	0.000878	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—STAR—type 2 diabetes mellitus	0.000175	0.000878	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000175	0.000878	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000175	0.000877	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UCP3—type 2 diabetes mellitus	0.000175	0.000877	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UCP2—type 2 diabetes mellitus	0.000175	0.000877	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000174	0.000872	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000169	0.00085	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000168	0.000844	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000168	0.000841	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CBS—type 2 diabetes mellitus	0.000168	0.000841	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000164	0.000824	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000162	0.000812	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000161	0.000811	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COX2—type 2 diabetes mellitus	0.000161	0.00081	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000161	0.00081	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000161	0.000807	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000159	0.000797	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000158	0.000796	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000158	0.000795	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000158	0.000792	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000158	0.000791	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	0.000156	0.000782	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	0.000156	0.000782	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000156	0.000782	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HK1—type 2 diabetes mellitus	0.000154	0.000772	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000154	0.000771	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000153	0.00077	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000151	0.000758	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000151	0.000756	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.00015	0.000754	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCKR—type 2 diabetes mellitus	0.000148	0.000746	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPA—type 2 diabetes mellitus	0.000148	0.000746	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000148	0.000746	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000148	0.000746	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000146	0.000735	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000144	0.000724	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000143	0.000717	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000142	0.000715	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000141	0.000706	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000138	0.000694	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HK1—type 2 diabetes mellitus	0.000137	0.000689	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000137	0.000688	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000137	0.000687	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000135	0.00068	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000134	0.000675	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000134	0.000672	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	0.000132	0.000665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000132	0.000665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000132	0.000665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPA—type 2 diabetes mellitus	0.000132	0.000665	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000132	0.000664	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000127	0.00064	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000127	0.000638	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000124	0.00062	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000123	0.000619	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTR—type 2 diabetes mellitus	0.000121	0.000608	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000121	0.000608	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000121	0.000607	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000121	0.000607	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000119	0.0006	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000119	0.0006	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000119	0.000596	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000118	0.000593	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000118	0.000593	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LIPC—type 2 diabetes mellitus	0.000118	0.000592	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HBA1—type 2 diabetes mellitus	0.000118	0.000592	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCK—type 2 diabetes mellitus	0.000118	0.000592	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000117	0.000589	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000117	0.000588	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000115	0.000578	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CETP—type 2 diabetes mellitus	0.000114	0.000571	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000112	0.000561	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.00011	0.000553	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000108	0.000542	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTR—type 2 diabetes mellitus	0.000108	0.000542	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000108	0.000542	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000107	0.000535	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000106	0.000533	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000106	0.000532	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SREBF1—type 2 diabetes mellitus	0.000106	0.000531	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SNAP25—type 2 diabetes mellitus	0.000106	0.000531	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PSMD6—type 2 diabetes mellitus	0.000106	0.000531	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000105	0.000529	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	0.000105	0.000528	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	0.000105	0.000528	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCK—type 2 diabetes mellitus	0.000105	0.000528	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000105	0.000525	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000104	0.000524	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CTGF—type 2 diabetes mellitus	0.000104	0.000521	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMGCR—type 2 diabetes mellitus	0.000103	0.000517	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000103	0.000516	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CETP—type 2 diabetes mellitus	0.000102	0.00051	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000101	0.00051	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000101	0.000506	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—INS—type 2 diabetes mellitus	0.0001	0.000502	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	9.84e-05	0.000494	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2E1—type 2 diabetes mellitus	9.67e-05	0.000486	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	9.67e-05	0.000486	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A1—type 2 diabetes mellitus	9.57e-05	0.00048	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1A2—type 2 diabetes mellitus	9.57e-05	0.00048	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.46e-05	0.000475	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	9.44e-05	0.000474	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	9.44e-05	0.000474	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	9.44e-05	0.000474	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP3A4—type 2 diabetes mellitus	9.33e-05	0.000468	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.28e-05	0.000466	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	9.26e-05	0.000465	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	9.18e-05	0.000461	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GCG—type 2 diabetes mellitus	9.17e-05	0.000461	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	9.17e-05	0.000461	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.05e-05	0.000455	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	8.98e-05	0.000451	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	8.92e-05	0.000448	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	8.78e-05	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	8.63e-05	0.000433	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	8.63e-05	0.000433	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	8.53e-05	0.000429	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	8.53e-05	0.000429	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	8.32e-05	0.000418	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.28e-05	0.000416	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GCG—type 2 diabetes mellitus	8.18e-05	0.000411	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	8.18e-05	0.000411	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.91e-05	0.000397	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	7.91e-05	0.000397	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	7.87e-05	0.000395	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAT—type 2 diabetes mellitus	7.76e-05	0.00039	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOB—type 2 diabetes mellitus	7.54e-05	0.000379	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	7.33e-05	0.000368	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPL—type 2 diabetes mellitus	7.2e-05	0.000361	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	7.05e-05	0.000354	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.05e-05	0.000354	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	7.05e-05	0.000354	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	7.02e-05	0.000353	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	7.02e-05	0.000353	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAT—type 2 diabetes mellitus	6.93e-05	0.000348	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CD36—type 2 diabetes mellitus	6.84e-05	0.000343	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	6.75e-05	0.000339	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOB—type 2 diabetes mellitus	6.72e-05	0.000338	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	6.54e-05	0.000328	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	6.48e-05	0.000325	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPL—type 2 diabetes mellitus	6.42e-05	0.000322	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	6.36e-05	0.000319	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	6.29e-05	0.000316	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	6.26e-05	0.000315	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AGT—type 2 diabetes mellitus	6.16e-05	0.000309	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CD36—type 2 diabetes mellitus	6.1e-05	0.000306	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	6.05e-05	0.000304	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOE—type 2 diabetes mellitus	6.03e-05	0.000303	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	6.02e-05	0.000303	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	5.96e-05	0.000299	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	5.78e-05	0.00029	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	5.67e-05	0.000285	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AGT—type 2 diabetes mellitus	5.49e-05	0.000276	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	5.4e-05	0.000271	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOE—type 2 diabetes mellitus	5.38e-05	0.00027	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	5.32e-05	0.000267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	5.25e-05	0.000264	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INS—type 2 diabetes mellitus	5.15e-05	0.000259	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—type 2 diabetes mellitus	4.72e-05	0.000237	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	4.69e-05	0.000235	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INS—type 2 diabetes mellitus	4.6e-05	0.000231	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	4.52e-05	0.000227	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	4.52e-05	0.000227	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—type 2 diabetes mellitus	4.22e-05	0.000212	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	4.13e-05	0.000208	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	4.03e-05	0.000202	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	4.03e-05	0.000202	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	3.69e-05	0.000185	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-05	0.000104	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-05	9.31e-05	CbGpPWpGaD
